No Data
No Data
Stifel Maintains Krystal Biotech(KRYS.US) With Buy Rating, Raises Target Price to $220
Stifel Nicolaus Remains a Buy on Krystal Biotech (KRYS)
Krystal Biotech, Inc. (KRYS): Promising Pipeline or Risky Gamble?
Krystal Biotech(KRYS.US) 10% Shareholder Sells US$9.89 Million in Common Stock
Krystal Biotech to Present at 2024 Cantor Global Healthcare Conference
Form 144 | Krystal Biotech(KRYS.US) Director Proposes to Sell 4.97 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Sep 12, $Krystal Biotech(KRYS.US)$ Director KRISH KRISHNAN intends to sell 25,000 shares of its common stock on Sep 12, with a total market value of approximately $4.97
No Data
No Data